ELAVL1 regulates alternative splicing of eIF4E transporter to promote postnatal angiogenesis Academic Article uri icon


MeSH Major

  • Alternative Splicing
  • ELAV Proteins
  • Neovascularization, Physiologic


  • Posttranscriptional RNA regulation is important in determining the plasticity of cellular phenotypes. However, mechanisms of how RNA binding proteins (RBPs) influence cellular behavior are poorly understood. We show here that the RBP embryonic lethal abnormal vision like 1 (ELAVL1, also know as HuR) regulates the alternative splicing of eukaryotic translation initiation factor 4E nuclear import factor 1 (Eif4enif1), which encodes an eukaryotic translation initiation factor 4E transporter (4E-T) protein and suppresses the expression of capped mRNAs. In the absence of ELAVL1, skipping of exon 11 of Eif4enif1 forms the stable, short isoform, 4E-Ts. This alternative splicing event results in the formation of RNA processing bodies (PBs), enhanced turnover of angiogenic mRNAs, and suppressed sprouting behavior of vascular endothelial cells. Further, endothelial-specific Elavl1 knockout mice exhibited reduced revascularization after hind limb ischemia and tumor angiogenesis in oncogene-induced mammary cancer, resulting in attenuated blood flow and tumor growth, respectively. ELAVL1-regulated alternative splicing of Eif4enif1 leading to enhanced formation of PB and mRNA turnover constitutes a novel posttranscriptional mechanism critical for pathological angiogenesis.

publication date

  • December 23, 2014



  • Academic Article



  • eng

PubMed Central ID

  • PMC4280608

Digital Object Identifier (DOI)

  • 10.1073/pnas.1412172111

PubMed ID

  • 25422430

Additional Document Info

start page

  • 18309

end page

  • 14


  • 111


  • 51